Capital Investment Counsel Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Hold
984
0.13% 88
2026
Q1
$905K Buy
984
+200
+26% +$203K 0.11% 100
2025
Q4
$843K Hold
784
0.1% 101
2025
Q3
$598K Buy
784
+13
+2% +$9.67K 0.07% 112
2025
Q2
$601K Buy
771
+89
+13% +$69.2K 0.08% 110
2025
Q1
$563K Buy
682
+40
+6% +$33.3K 0.08% 108
2024
Q4
$496K Sell
642
-103
-14% -$85.3K 0.07% 111
2024
Q3
$660K Hold
745
0.09% 102
2024
Q2
$675K Buy
745
+142
+24% +$114K 0.1% 96
2024
Q1
$469K Hold
603
0.08% 117
2023
Q4
$352K Buy
603
+103
+21% +$60.1K 0.06% 130
2023
Q3
$269K Hold
500
0.05% 139
2023
Q2
$234K Buy
+500
New +$210K 0.05% 148

Other funds holding LLY

Capital Investment Counsel Inc's LLY Position: Q2 2026 in Review

Capital Investment Counsel Inc held its Eli Lilly (LLY) position steady in Q2 2026 at 984 shares worth $1.18M. The position accounts for 0.13% of the portfolio, ranked #88.

Capital Investment Counsel Inc first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Capital Investment Counsel Inc held 984 shares of Eli Lilly worth $1.18M as of Q2 2026.
  • Capital Investment Counsel Inc left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.13% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #88 holding.
  • Capital Investment Counsel Inc first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.